Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | AMGN | BMY | GILD | ILMN |
| Company | Adma Biologics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.87 | 337.03 | 49.89 | 84.39 | 134.92 |
| High | 19.92 | 338.70 | 50.04 | 84.65 | 136.19 |
| Low | 18.81 | 334.61 | 48.95 | 83.43 | 133.81 |
| Last | 19.74 | 335.95 | 49.02 | 83.90 | 134.39 |
| Change | +0.42 | +3.03 | -0.72 | +0.01 | +3.42 |
| % Change | +2.17% | +0.91% | -1.45% | +0.01% | +2.61% |
| Volume | 5,489,600 | 1,626,200 | 8,841,430 | 8,798,100 | 1,215,800 |
| 20-Day Average Volume | 4,460,895 | 1,760,685 | 8,610,145 | 6,694,925 | 1,354,870 |
| Previous Close | 19.32 | 332.92 | 49.74 | 83.89 | 130.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.66 | 329.59 | 49.09 | 80.07 | 129.20 |
| 20-Day Raw Stochastic | 95.34% | 84.75% | 55.24% | 89.62% | 88.52% |
| 20-Day Relative Strength | 67.61% | 57.67% | 54.18% | 71.87% | 60.50% |
| Weighted Alpha | +395.58 | +27.09 | -11.20 | +18.24 | +8.47 |
| Today's Opinion | 100% Buy | 96% Buy | 56% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.84% since 09/12/24 | +1.78% since 09/12/24 | +1.62% since 09/12/24 | +0.89% since 09/12/24 | +6.45% since 09/12/24 |
| Low | 17.70 on 09/16/24 | 327.15 on 09/13/24 | 48.20 on 09/13/24 | 81.57 on 09/13/24 | 126.31 on 09/13/24 |
| High | 19.92 on 09/19/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +8.34% since 08/19/24 | +2.43% since 08/19/24 | -0.57% since 08/19/24 | +12.69% since 08/19/24 | -1.11% since 08/19/24 |
| Low | 16.06 on 09/04/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 | 120.51 on 09/12/24 |
| High | 19.92 on 09/19/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | +85.88% since 06/18/24 | +9.79% since 06/18/24 | +20.12% since 06/18/24 | +32.86% since 06/18/24 | +24.32% since 06/18/24 |
| Low | 10.21 on 08/05/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 103.52 on 06/28/24 |
| High | 19.92 on 09/19/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +218.90% since 03/19/24 | +23.63% since 03/19/24 | -5.37% since 03/19/24 | +14.29% since 03/19/24 | +0.92% since 03/19/24 |
| Low | 5.89 on 04/10/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 100.08 on 05/30/24 |
| High | 19.92 on 09/19/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,478,550 | 178,589,936 | 100,827,960 | 104,514,608 | 20,863,522 |
| Shares Outstanding, K | 231,809 | 536,435 | 2,027,100 | 1,245,853 | 159,300 |
| Annual Sales | 258,220,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -28,240,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 107,190,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 1,112,000,000 |
| Last Quarter Net Income | 32,060,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,988,000,000 |
| 60-Month Beta | 0.61 | 0.61 | 0.46 | 0.18 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/08/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 08/08/24 | 10/29/24 | 10/31/24 | 11/05/24 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 71.96 | 17.89 | 36.12 | 17.67 | 141.53 |